Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Drugs with antidepressant properties affect tryptophan metabolites differently in rodent models with depression‐like behavior
Amanda Eskelund, Yan Li, David P. Budac, et al.
Journal of Neurochemistry (2017) Vol. 142, Iss. 1, pp. 118-131
Open Access | Times Cited: 44

Showing 1-25 of 44 citing articles:

Kynurenine pathway in depression: A systematic review and meta-analysis
Kamiyu Ogyu, Kaoruhiko Kubo, Yoshihiro Noda, et al.
Neuroscience & Biobehavioral Reviews (2018) Vol. 90, pp. 16-25
Closed Access | Times Cited: 241
Microglia: An Interface between the Loss of Neuroplasticity and Depression
Gaurav Singhal, Bernhard T. Baune
Frontiers in Cellular Neuroscience (2017) Vol. 11
Open Access | Times Cited: 191
Post-COVID-19 Depressive Symptoms: Epidemiology, Pathophysiology, and Pharmacological Treatment
Mario Gennaro Mazza, Mariagrazia Palladini, Sara Poletti, et al.
CNS Drugs (2022) Vol. 36, Iss. 7, pp. 681-702
Open Access | Times Cited: 158
Neuroinflammation and the Kynurenine Pathway in CNS Disease: Molecular Mechanisms and Therapeutic Implications
Mustafa N. Mithaiwala, Danielle Santana‐Coelho, Grace A. Porter, et al.
Cells (2021) Vol. 10, Iss. 6, pp. 1548-1548
Open Access | Times Cited: 117
Age‐ and disease‐specific changes of the kynurenine pathway in Parkinson’s and Alzheimer’s disease
Freek J. H. Sorgdrager, Yannick Vermeiren, Martijn van Faassen, et al.
Journal of Neurochemistry (2019) Vol. 151, Iss. 5, pp. 656-668
Open Access | Times Cited: 114
The kynurenine pathway and bipolar disorder: intersection of the monoaminergic and glutamatergic systems and immune response
Bashkim Kadriu, Cristan Farmer, Peixiong Yuan, et al.
Molecular Psychiatry (2019) Vol. 26, Iss. 8, pp. 4085-4095
Open Access | Times Cited: 77
The kynurenine pathway in major depression: What we know and where to next
Samara Brown, Xu‐Feng Huang, Kelly A. Newell
Neuroscience & Biobehavioral Reviews (2021) Vol. 127, pp. 917-927
Closed Access | Times Cited: 67
Rapid response to selective serotonin reuptake inhibitors in post-COVID depression
Mario Gennaro Mazza, Raffaella Zanardi, Mariagrazia Palladini, et al.
European Neuropsychopharmacology (2021) Vol. 54, pp. 1-6
Open Access | Times Cited: 62
Efficacy of Vortioxetine on Anhedonia: Results from a Pooled Analysis of Short-Term Studies in Patients with Major Depressive Disorder
Roger S. McIntyre, Henrik Loft, Michael Cronquist Christensen
Neuropsychiatric Disease and Treatment (2021) Vol. Volume 17, pp. 575-585
Open Access | Times Cited: 59
Ketamine’s effect on inflammation and kynurenine pathway in depression: A systematic review
Emma I Kopra, Valeria Mondelli, Carmine M. Pariante, et al.
Journal of Psychopharmacology (2021) Vol. 35, Iss. 8, pp. 934-945
Open Access | Times Cited: 57
How Oxidative Stress Induces Depression?
Na Ji, Mengzhu Lei, Yating Chen, et al.
ASN NEURO (2023) Vol. 15
Open Access | Times Cited: 27
Long COVID: Complications, Underlying Mechanisms, and Treatment Strategies
Farigol Hakem Zadeh, Daniel R. Wilson, Devendra K. Agrawal
Archives of Microbiology & Immunology (2023) Vol. 07, Iss. 02
Open Access | Times Cited: 26
Brain Kynurenine and BH4 Pathways: Relevance to the Pathophysiology and Treatment of Inflammation-Driven Depressive Symptoms
Sylvie Vancassel, Lucile Capuron, Nathalie Castanon
Frontiers in Neuroscience (2018) Vol. 12
Open Access | Times Cited: 73
Vortioxetine for Cognitive Enhancement in Major Depression: From Animal Models to Clinical Research
Djamila Bennabi, Émmanuel Haffen, Vincent Van Waes
Frontiers in Psychiatry (2019) Vol. 10
Open Access | Times Cited: 61
Sex- and suicide-specific alterations in the kynurenine pathway in the anterior cingulate cortex in major depression
Samara Brown, Katerina Christofides, Christin Weissleder, et al.
Neuropsychopharmacology (2023) Vol. 49, Iss. 3, pp. 584-592
Open Access | Times Cited: 20
Effect of vortioxetine and fluoxetine on immunohistochemical expression of Caspase-8, RANKL, and IL-6 in testicular tissue in an experimental depression model
Gamze Erkılınç, G. Ozdamar, Özlem Özmen, et al.
Biotechnic & Histochemistry (2025), pp. 1-9
Closed Access
Potencial Terapêutico da Vortioxetina: Respostas Cardíacas ao Estresse Crônico Moderado Imprevisível em um Modelo de Rato
Özlem Özmen, Şerife Taşan, Güli̇n Özdamar Ünal
Arquivos Brasileiros de Cardiologia (2025) Vol. 122, Iss. 2
Open Access
Vortioxetine’s Therapeutic Potential: Cardiac Responses to Chronic Unpredictable Mild Stress in a Rat Model
Özlem Özmen, Şerife Taşan, Güli̇n Özdamar Ünal
Arquivos Brasileiros de Cardiologia (2025) Vol. 122, Iss. 2
Open Access
Decoding tryptophan: Pioneering new frontiers in systemic lupus erythematosus
Fugang Huang, Ke Sun, Jiawang Zhou, et al.
Autoimmunity Reviews (2025), pp. 103809-103809
Closed Access
Central levels of tryptophan metabolites in subjects with bipolar disorder
Ada Trepci, Carl M. Sellgren, Erik Pålsson, et al.
European Neuropsychopharmacology (2020) Vol. 43, pp. 52-62
Open Access | Times Cited: 30
Comparison of the Psychopharmacological Effects of Tiletamine and Ketamine in Rodents
Piotr Popik, Małgorzata Hołuj, Tomasz Kos, et al.
Neurotoxicity Research (2017) Vol. 32, Iss. 4, pp. 544-554
Open Access | Times Cited: 30
Pharmacological Modulation of the Psychiatric Risk Factor FKBP51 Alters Efficiency of Common Antidepressant Drugs
Max L. Pöhlmann, Alexander S. Häusl, Daniela Harbich, et al.
Frontiers in Behavioral Neuroscience (2018) Vol. 12
Open Access | Times Cited: 30
Is the Therapeutic Mechanism of Repetitive Transcranial Magnetic Stimulation in Cognitive Dysfunctions of Depression Related to the Neuroinflammatory Processes in Depression?
Hiroshi Tateishi, Yoshito Mizoguchi, Akira Monji
Frontiers in Psychiatry (2022) Vol. 13
Open Access | Times Cited: 14
Vortioxetine as an alternative treatment for somatic symptom disorder: case report
Naoki Furutani, Yasuhide Nagoshi
Frontiers in Psychiatry (2024) Vol. 15
Open Access | Times Cited: 2
Systematic Review of the Kynurenine Pathway and Psychoneurological Symptoms Among Adult Cancer Survivors
Hongjin Li, Tingting Liu, Lacey W. Heinsberg, et al.
Biological Research For Nursing (2020) Vol. 22, Iss. 4, pp. 472-484
Open Access | Times Cited: 16
Page 1 - Next Page

Scroll to top